Considering the crucial role of microglial inflammasome/caspase-1/IL-1β axis in neuroinflammation8,53, we propose that the inhibition of DAPK1 represents a potential therapeutic application for IL-1β-associated neurological diseases. Here, CASP1 is linked to nervous system disorder.